Enlivex Therapeutics LTD. 6-K Filing
Ticker: ENLV · Form: 6-K · Filed: Nov 24, 2025 · CIK: 1596812
Sentiment: neutral
Filing Stats: 339 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2025-11-24 06:55:41
Filing Documents
- ea0266869-6k_enlivex.htm (6-K) — 11KB
- ea026686901ex99-1_enlivex.htm (EX-99.1) — 18KB
- ea026686901ex99-2_enlivex.htm (EX-99.2) — 39KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- ex99-2_001.jpg (GRAPHIC) — 85KB
- ex99-2_002.jpg (GRAPHIC) — 334KB
- ex99-2_003.jpg (GRAPHIC) — 194KB
- ex99-2_004.jpg (GRAPHIC) — 277KB
- ex99-2_005.jpg (GRAPHIC) — 255KB
- ex99-2_006.jpg (GRAPHIC) — 271KB
- ex99-2_007.jpg (GRAPHIC) — 173KB
- ex99-2_008.jpg (GRAPHIC) — 70KB
- ex99-2_009.jpg (GRAPHIC) — 187KB
- ex99-2_010.jpg (GRAPHIC) — 242KB
- ex99-2_011.jpg (GRAPHIC) — 213KB
- ex99-2_012.jpg (GRAPHIC) — 104KB
- ex99-2_013.jpg (GRAPHIC) — 220KB
- ex99-2_014.jpg (GRAPHIC) — 196KB
- ex99-2_015.jpg (GRAPHIC) — 92KB
- ex99-2_016.jpg (GRAPHIC) — 267KB
- ex99-2_017.jpg (GRAPHIC) — 208KB
- ex99-2_018.jpg (GRAPHIC) — 224KB
- ex99-2_019.jpg (GRAPHIC) — 165KB
- ex99-2_020.jpg (GRAPHIC) — 196KB
- ex99-2_021.jpg (GRAPHIC) — 196KB
- ex99-2_022.jpg (GRAPHIC) — 208KB
- ex99-2_023.jpg (GRAPHIC) — 206KB
- ex99-2_024.jpg (GRAPHIC) — 303KB
- ex99-2_025.jpg (GRAPHIC) — 271KB
- ex99-2_026.jpg (GRAPHIC) — 282KB
- ex99-2_027.jpg (GRAPHIC) — 206KB
- ex99-2_028.jpg (GRAPHIC) — 127KB
- ex99-2_029.jpg (GRAPHIC) — 230KB
- ex99-2_030.jpg (GRAPHIC) — 43KB
- 0001213900-25-113831.txt ( ) — 8402KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Enlivex Therapeutics Ltd. (Registrant) By: /s/ Oren Hershkovitz Name: Oren Hershkovitz Title: Chief Executive Officer Date: November 24, 2025 2